ArticleCanadian family physician Medecin de famille canadien2026
Prednisone prescribing for rheumatoid arthritis management in primary care: Mixed-methods study of trends and patient perspectives.
Article in Canadian family physician Medecin de famille canadien, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo examine patterns of prednisone prescribing for rheumatoid arthritis (RA) management in primary care settings; and to explore experiences and perspectives of family physicians (FPs) and people living with RA regarding prednisone use.
designMixed-methods study with sequential exploratory design.
settingCanada, particularly Alberta.
participantsOverall, 546 patients with RA in primary care electronic medical records in southern Alberta after excluding short-term prednisone prescriptions, 33 people living with RA from across Canada, and 16 primary care providers (14 family physicians, 1 clinic manager, 1 pharmacist).
methodsQualitative interviews and focus groups guided the analysis of primary care electronic medical records linked with provincial pharmaceutical dispensing data. Patterns of prednisone dispensing over 12 years, factors associated with prednisone use before and after RA documentation, and qualitative experiences with prednisone therapy were examined. MAIN
findingsEach year between 2008 and 2019, at least 40% of patients with established RA received at least 1 prednisone prescription. Of patients receiving both prednisone and disease-modifying antirheumatic drugs (DMARDs) (41%, n=210), a subset (n=92) received prednisone before starting DMARDs, with 66% continuing prednisone for more than a year after DMARD initiation. Median time between first prednisone prescription and DMARD initiation was 124 days (interquartile range=13 to 1150 days). Three main qualitative themes were identified: prednisone is used as bridging therapy during the wait time to see a specialist, patients and providers have concerns about long-term use and side effects, and systemic barriers affecting access to guideline-concordant care exist and particularly impact male patients.
conclusionCurrent prednisone prescribing patterns in RA management reveal divergence from guidelines recommending short-term use, suggesting systemic barriers to guideline-concordant care. Improving outcomes requires addressing both clinical needs driving prednisone use and systemic barriers perpetuating reliance on this medication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.